fluocinolone acetonide has been researched along with Retinal Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrà moff, MD; Chen, Z; Folk, JC; Gerendas, BS; Lee, K; Lynch, SK; Schmidt-Erfurth, U; Wahle, A; Wykoff, CC | 1 |
| Abrams, GW; Ashton, P; Glybina, IV; Iezzi, R; Kennedy, A | 1 |
| Glybina, IV; Guru, BR; Iezzi, R; Kannan, RM; Kennedy, A; Mishra, MK | 1 |
3 other study(ies) available for fluocinolone acetonide and Retinal Degeneration
| Article | Year |
|---|---|
Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Logistic Models; Macular Edema; Male; Middle Aged; Pilot Projects; Retinal Degeneration; Retrospective Studies; Tomography, Optical Coherence | 2019 |
Intravitreous delivery of the corticosteroid fluocinolone acetonide attenuates retinal degeneration in S334ter-4 rats.
Topics: Animals; Animals, Genetically Modified; Cell Count; Disease Models, Animal; Drug Delivery Systems; Electroretinography; Fluocinolone Acetonide; Glucocorticoids; Microglia; Rats; Retina; Retinal Degeneration; Vitreous Body | 2010 |
Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration.
Topics: Animals; Anti-Inflammatory Agents; Dendrimers; Electroretinography; Fluocinolone Acetonide; Inflammation; Intravitreal Injections; Neuroimmunomodulation; Rats; Retinal Degeneration | 2012 |